Scaling CAR-T Therapies: Clinical Delivery, Workforce and System Readiness
How do we scale CAR-T? Exploring clinical delivery, workforce skills and system readiness. FREE to attend. CAR-T cell therapies have delivered transformative outcomes for cancer patients who have exhausted other treatment options, and are increasingly being explored across a wider range of indications. However, expanding patient access remains challenging. The complexity and cost of CAR-T manufacturing, spanning both clinical and…